Thyrocare Technologies Limited has informed the Exchange regarding Change in Auditors of the company.
THYROCARE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Thyrocare Technologies held a board meeting on May 7, 2026, approving several key matters. The company recommended a final dividend of Rs. 7 per share for FY 2025-26, taking total dividend to Rs. 9.33 per share (post bonus adjustment). Statutory auditors will change from M S K A & Associates LLP to Price Waterhouse Chartered Accountants LLP for a 5-year term, with the existing auditors completing their tenure. Two Non-Executive Non-Independent Directors resigned citing pre-occupation (Dharmil Nirupam Sheth and Dr. Dhaval Rajesh Shah), while two new directors (Uday Patel Kadam and Gaurav Verma) were appointed. CEO Rahul Franklin Guha was re-appointed for 5 years. The company also approved up to Rs. 5.5 crore investment in its wholly owned subsidiary Think Health Diagnostics and proposed amendments to its Memorandum of Association to expand healthcare activities.
The resignation of two directors on the same day and appointment of two new directors from API Holdings indicates significant board restructuring. Shareholders should note the upcoming auditor change and expanded business scope proposals.